23214-92-8 Doxorubicin 98%

Amol Deshmukh brings over 21 years of valuable experience in the pharmaceutical industry, specifically in API, intermediate, and custom synthesis. His journey includes significant roles at Emcure and Lupin, where he developed expertise in various aspects of the field.

Amol is known for his role in establishing effective Standard Operating Procedures (SOP) for Process Development and Scaling up of API on a commercial scale. This highlights his dedication to ensuring efficient and quality-driven processes.

With a knack for leading cross-functional teams, Amol has overseen the design and preparation of intermediates and final molecules for extensive library projects. His involvement in Hit-to-Lead programs has resulted in the successful design and delivery of several novel chemistries, contributing to a robust intellectual property portfolio and maintaining a competitive edge in innovations.

As an effective communicator and dedicated team player, Amol possesses excellent problem-solving and team management skills. His ability to handle multiple projects simultaneously while maintaining quality and meeting strict deadlines showcases his commitment to excellence.

Driven by a passion for innovation and success in the pharmaceutical industry, Amol is enthusiastic about utilizing his skills and experience to contribute to the growth and success of any organization.